Report Categories
View AllRecent Articles
View All
Radiopharm RADX at 473 Buy Sell or Hold 20260515
Bronstein Gewirtz Grossman LLC Announces Class Action Lawsuit Against Hercules Capital Inc Investors Urged to Act
Should You Sell Eagle ECC After 086 Drop 20260515
Why Millrose Properties MRP Just Dropped 185 What to Watch 20260515
Burberry Shares Rise on Report of Potential Moncler Takeover Bid
USChina Tariff Ease Fails to Mend Trust as Chinese Companies Pursue US Market with Caution
German Business Morale Unexpectedly Improves in May Amid Iran War Energy Disruptions
Global Markets Oil Prices Fluctuate Following US Military Strikes in Southern Iran
Microsofts New Trusted Tech Lead Navigates Speed vs Responsibility in AI Development
Amazon UK Chief Says Education System Failing Young Workers Urges Shift in Blame
BWXT Q1 2026 Earnings Strong EPS Beat Driven by Operational Excellence
OCCIN Q1 2026 Earnings Massive EPS Miss Casts Doubt on Portfolio Performance
FHN Q1 2026 Earnings EPS Beats Estimates as Capital Strength Shines
MLI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Robust Demand
WPRT Q1 2026 Earnings BetterthanExpected EPS but Stock Declines
Nextpower Inc NXT Q1 2026 Earnings EPS Beat of 1316 Overshadowed by Stock Decline
Moolec Science MLEC Rallies 345 as Volume Picks Up Approaches Key 788 Resistance
Tilray Brands TLRY Rises 225 as Cannabis Sector Shows Renewed Momentum
Dyadic International DYAI Slides Lower Testing Key Support Near 072
Public Service Enterprise Group PEG Shows Modest Uptick Amid Utility Sector Stability
Walmart WMT Slips 088 as Retail Giant Fights at Support
Cellectis CLLS Stock Dips 127 as Biotech Volatility Persists Key Support at 332 in Focus
Georgia Power Preferred GPJA Rises Modestly as FixedIncome Appeal Remains in Focus
Terrestrial Energy Inc IMSR Surges Over 8 on Renewed Investor Interest
Nanobiotix NBTX Gains Momentum Testing Resistance After 2 Uptick
Rithm Capital RITM Holds Steady at 926 Amid Sideways Trading
External Links
1100 Architect Named to Forbes Americas Top Architects 2025 Expands Bold Presence Near Boston
ImmunityBio Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss
BeOne Medicines ONC Edges Higher Amid Sector Volatility Key Levels in Focus
Nu Skin Enterprises Q1 2026 Earnings EPS Misses Estimates Shares Dip Slightly
Marriott Vacations Worldwide VAC Q1 2026 Earnings EPS Miss Weighs on Sentiment but Stock Ticks Higher
METC Q1 2026 Earnings Coal Producer Misses Estimates Amid Demand Headwinds
Capital Bancorp Inc CBNK Q1 2026 Earnings EPS Misses Estimates Amid Margin Pressures
MGX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline
YORW Q1 2026 Earnings EPS Beats Estimates as Regulated Utility Shows Steady Performance
MITP Q1 2026 Earnings EPS Surpasses Estimates by 535